JUBLPHARMA.BOJUBLPHARMA.BOBSE
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+4.2%
5Y CAGR+4.5%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+4.2%/yr
vs +6.4%/yr prior
5Y CAGR
+4.5%/yr
Consistent
Acceleration
-2.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
5 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$23.43B+2.4%
2024$22.87B+3.3%
2023$22.15B+6.8%
2022$20.74B+6.7%
2021$19.44B+3.2%
2020$18.84B-6.2%
2019$20.09B+24.1%
2018$16.19B+26.5%
2017$12.79B+9.6%
2016$11.67B-